BACKGROUND: Dexamethasone-phosphate (Dex-PO4) and the combination betamethasone-phosphate (Beta-PO4) + betamethasone-acetate (Beta-Ac) are the most used antenatal corticosteroids to promote fetal lung maturation. We compared fetal lung maturation induced by Beta-Ac+Beta-PO4, Dex-PO4, or Beta-PO4 alone. METHODS: Pregnant ewes received two intramuscular doses 24 h apart of 0.25 mg/kg/dose of Beta-Ac+Beta-PO4, Dex-PO4 or Beta-PO4; or 2 doses of 0.125 mg/kg/dose of Beta-PO4 at 6, 12, or 24 h intervals. Fetuses were delivered 48 h after the first dose and ventilated for 30 min. We assessed ventilatory variables, vital signs, and blood gas. After ventilation pressure-volume curves were measured and lungs were sampled for analysis. RESULTS: All treatments improved lung compliance and ventilation efficiency. Only Beta-Ac + Beta-PO4 required lower positive inspiratory pressure compared with control. Beta-Ac + Beta-PO4 and Beta-PO4 alone, but not Dex-PO4, increased the mRNA of surfactant proteins compared with control. Low-dose Beta-PO4 did not increase mRNA of surfactant proteins. There were no differences among Beta-PO4 treatment intervals. CONCLUSION: Beta-Ac + Beta-PO4 given as two doses 24 h apart was more effective in promoting fetal lung maturation than Dex-PO4 or Beta-PO4 alone, consistent with a prolonged exposure provided by the Beta-Ac + Beta-PO4. These results support the clinical use of combined Beta-Ac + Beta-PO4 preparations over phosphate corticosteroids alone for fetal lung maturation.
BACKGROUND:Dexamethasone-phosphate (Dex-PO4) and the combination betamethasone-phosphate (Beta-PO4) + betamethasone-acetate (Beta-Ac) are the most used antenatal corticosteroids to promote fetal lung maturation. We compared fetal lung maturation induced by Beta-Ac+Beta-PO4, Dex-PO4, or Beta-PO4 alone. METHODS: Pregnant ewes received two intramuscular doses 24 h apart of 0.25 mg/kg/dose of Beta-Ac+Beta-PO4, Dex-PO4 or Beta-PO4; or 2 doses of 0.125 mg/kg/dose of Beta-PO4 at 6, 12, or 24 h intervals. Fetuses were delivered 48 h after the first dose and ventilated for 30 min. We assessed ventilatory variables, vital signs, and blood gas. After ventilation pressure-volume curves were measured and lungs were sampled for analysis. RESULTS: All treatments improved lung compliance and ventilation efficiency. Only Beta-Ac + Beta-PO4 required lower positive inspiratory pressure compared with control. Beta-Ac + Beta-PO4 and Beta-PO4 alone, but not Dex-PO4, increased the mRNA of surfactant proteins compared with control. Low-dose Beta-PO4 did not increase mRNA of surfactant proteins. There were no differences among Beta-PO4 treatment intervals. CONCLUSION:Beta-Ac + Beta-PO4 given as two doses 24 h apart was more effective in promoting fetal lung maturation than Dex-PO4 or Beta-PO4 alone, consistent with a prolonged exposure provided by the Beta-Ac + Beta-PO4. These results support the clinical use of combined Beta-Ac + Beta-PO4 preparations over phosphate corticosteroids alone for fetal lung maturation.
Authors: O Baud; L Foix-L'Helias; M Kaminski; F Audibert; P H Jarreau; E Papiernik; C Huon; J Lepercq; M Dehan; T Lacaze-Masmonteil Journal: N Engl J Med Date: 1999-10-14 Impact factor: 91.245
Authors: D A Guinn; M W Atkinson; L Sullivan; M Lee; S MacGregor; B V Parilla; J Davies; K Hanlon-Lundberg; L Simpson; J Stone; D Wing; K Ogasawara; J Muraskas Journal: JAMA Date: 2001-10-03 Impact factor: 56.272
Authors: Alan H Jobe; Timothy J M Moss; Ilias Nitsos; Machiko Ikegami; Suhas G Kallapur; John P Newnham Journal: Am J Obstet Gynecol Date: 2007-11 Impact factor: 8.661
Authors: Graeme R Polglase; Noah H Hillman; J Jane Pillow; Fook-Choe Cheah; Ilias Nitsos; Timothy J M Moss; Boris W Kramer; Machiko Ikegami; Suhas G Kallapur; Alan H Jobe Journal: Pediatr Res Date: 2008-11 Impact factor: 3.756
Authors: Fernando Althabe; José M Belizán; Elizabeth M McClure; Jennifer Hemingway-Foday; Mabel Berrueta; Agustina Mazzoni; Alvaro Ciganda; Shivaprasad S Goudar; Bhalachandra S Kodkany; Niranjana S Mahantshetti; Sangappa M Dhaded; Geetanjali M Katageri; Mrityunjay C Metgud; Anjali M Joshi; Mrutyunjaya B Bellad; Narayan V Honnungar; Richard J Derman; Sarah Saleem; Omrana Pasha; Sumera Ali; Farid Hasnain; Robert L Goldenberg; Fabian Esamai; Paul Nyongesa; Silas Ayunga; Edward A Liechty; Ana L Garces; Lester Figueroa; K Michael Hambidge; Nancy F Krebs; Archana Patel; Anjali Bhandarkar; Manjushri Waikar; Patricia L Hibberd; Elwyn Chomba; Waldemar A Carlo; Angel Mwiche; Melody Chiwila; Albert Manasyan; Sayury Pineda; Sreelatha Meleth; Vanessa Thorsten; Kristen Stolka; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens Journal: Lancet Date: 2014-10-15 Impact factor: 79.321
Authors: Augusto F Schmidt; Matthew W Kemp; Judith Rittenschober-Böhm; Paranthaman S Kannan; Haruo Usuda; Masatoshi Saito; Lucy Furfaro; Shimpei Watanabe; Sarah Stock; Boris W Kramer; John P Newnham; Suhas G Kallapur; Alan H Jobe Journal: Am J Obstet Gynecol Date: 2017-11-11 Impact factor: 8.661
Authors: Augusto F Schmidt; Paranthaman S Kannan; James P Bridges; Alyssa Filuta; Dakota Lipps; Matthew Kemp; Lisa A Miller; Suhas G Kallapur; Yan Xu; Jeffrey A Whitsett; Alan H Jobe Journal: Sci Rep Date: 2019-06-21 Impact factor: 4.379
Authors: René Schiffner; Guadalupe L Rodríguez-González; Florian Rakers; Marius Nistor; Peter W Nathanielsz; Teodora Daneva; Matthias Schwab; Thomas Lehmann; Martin Schmidt Journal: Int J Mol Sci Date: 2017-10-27 Impact factor: 5.923
Authors: David Perna-Barrull; Anna Gieras; Silvia Rodriguez-Fernandez; Eva Tolosa; Marta Vives-Pi Journal: Front Endocrinol (Lausanne) Date: 2020-08-11 Impact factor: 5.555
Authors: Alan H Jobe; Matthew Kemp; Augusto Schmidt; Tsukasa Takahashi; John Newnham; Mark Milad Journal: Pediatr Res Date: 2020-11-11 Impact factor: 3.756